Gene · 6523
Papers3,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sugar binding of sodium-glucose cotransporters analyzed by voltage-clamp fluorometry. | J Biol Chem | 2024 | 38522518 | PubTator, text mining | PubMed |
| Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts. | Rev Esp Cardiol (Engl Ed) | 2024 | 38521442 | PubTator, text mining | PubMed |
| Genetic Evidence of Causal Relation Between Intestinal Glucose Absorption and Early Postprandial Glucose Response: A Mendelian Randomization Study. | Diabetes | 2024 | 38498375 | PubTator, text mining | PubMed |
| A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin. | Clin Pharmacol Ther | 2024 | 38456487 | PubTator, text mining | PubMed |
| Importance of genetic sequencing studies in managing chronic neonatal diarrhea: a case report of a novel variant in the glucose-galactose transporter SLC5A1. | Front Pediatr | 2024 | 38440183 | PubTator, text mining | PubMed |
| SGLT2 inhibitors: cardiorenal metabolic drugs for the ages. | J Clin Invest | 2024 | 38426504 | PubTator, text mining | PubMed |
| Advances in Understanding the Interplay between Dietary Practices, Body Composition, and Sports Performance in Athletes. | Nutrients | 2024 | 38398895 | PubTator, text mining | PubMed |
| XBP1-mediated transcriptional regulation of SLC5A1 in human epithelial cells in disease conditions. | Cell Biosci | 2024 | 38388523 | PubTator, text mining | PubMed |
| Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies. | BMC Cancer | 2024 | 38373930 | PubTator, text mining | PubMed |
| Fenugreek derived diosgenin as an emerging source for diabetic therapy. | Front Nutr | 2024 | 38371502 | PubTator, text mining | PubMed |
| Mechanistic Modeling of Empagliflozin: Predicting Pharmacokinetics, Urinary Glucose Excretion, and Investigating Compensatory Role of SGLT1 in Renal Glucose Reabsorption. | J Clin Pharmacol | 2024 | 38363006 | PubTator, text mining | PubMed |
| Medicinal Chemistry Strategies for the Modification of Bioactive Natural Products. | Molecules | 2024 | 38338433 | PubTator, text mining | PubMed |
| Physiological functions of glucose transporter-2: From cell physiology to links with diabetes mellitus. | Heliyon | 2024 | 38333863 | PubTator, text mining | PubMed |
Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature. | Heart Fail Rev | 2024 | 38300379 | PubTator, text mining | PubMed |
| Bridging the gap: glucose transporters, Alzheimer's, and future therapeutic prospects. | Front Cell Dev Biol | 2024 | 38298219 | PubTator, text mining | PubMed |
| Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome. | iScience | 2024 | 38292434 | PubTator, text mining | PubMed |
| Effect of an NHE3 inhibitor in combination with an NPT2b inhibitor on gastrointestinal phosphate absorption in Rodent models. | PLoS One | 2024 | 38277356 | PubTator, text mining | PubMed |
| Cow's Milk: A Benefit for Human Health? Omics Tools and Precision Nutrition for Lactose Intolerance Management. | Nutrients | 2024 | 38276558 | PubTator, text mining | PubMed |
| Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis. | Sci Rep | 2024 | 38273008 | PubTator, text mining | PubMed |
| Intestinal Morphology and Glucose Transporter Gene Expression under a Chronic Intake of High Sucrose. | Nutrients | 2024 | 38257088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6523/papers?page=11